Trials / Completed
CompletedNCT01231997
Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (estimated)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- Male
- Age
- 19 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to assess the effect of renal impairment on the pharmacokinetics, safety and tolerability of udenafil in subjects with renal impairment compared to healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Udenafil | 100mg Single Oral Dose of |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-11-01
- First posted
- 2010-11-02
- Last updated
- 2010-11-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01231997. Inclusion in this directory is not an endorsement.